How difficult of a drug is Enbrel to copy? Any idea if other companies can do this as easily as MNTA?
When the FDA approves FoB's are they 100% sure they are exact copies or is that something a company could dispute. For example could MNTA show that a competitors Humira is not identical?
Market Data 
Markets 
AI
